• standardize definitions of key elements of the schedule, and relevant health outcomes;
  • establish research priorities on the basis of epidemiological evidence, biological plausibility, and feasibility; and
  • continue to fund and support the Vaccine Safety Datalink project to study the safety of the recommended immunization schedule.


The National Academies of Sciences, Engineering, and Medicine
500 Fifth St. N.W. | Washington, D.C. 20001

Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement